No, he can’t say that, because publication route was decided before unblinding. Listen closely BSB, even Ex thinks they succeeded on four endpoints — including the primary endpoint. <br /> <br /> There are six endpoints in all. <br /> <br /> Most on this message board believe DCVax-l either met five of six, or six of six endpoints. <br /> <br /> What he did tell femike, was that they are working toward possible approval, and that they can’t rush the Journal, but the lack of a current public TLD announcement wasn’t slowing any efforts to try and obtain approval.